🇺🇸 FDA
Pipeline program

aspirin and/or clopidogrel

PZ-1001-403-NS

Approved small_molecule active

Quick answer

aspirin and/or clopidogrel for Early Gastric Cancer is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Early Gastric Cancer
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials